Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nasopharyngeal Neoplasms × Induction Chemotherapy × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 5 Rectal Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Nasopharyngeal Neoplasms 1 Lung Neoplasms 1 Locally Advanced Malignant Neoplasm 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasm Female 1 Anus Neoplasms 1

Interventions

Gemcitabine 8 Cisplatin 8 Radiotherapy, Intensity-Modulated 3 tislelizumab 2 nimotuzumab 2 camrelizumab 2 Fluorouracil 2 Carboplatin 2 pembrolizumab 1 fosaprepitant 1 etoposide phosphate 1 Tropisetron 1 Induction Chemotherapy 1 Ifosfamide 1 Etoposide 1 Docetaxel 1 Dexamethasone 1 Chemotherapy, Adjuvant 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00828386 2019-01-18

NPC2006

Groupe Oncologie Radiotherapie Tete et Cou

Phase 3 Terminated

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡